Cargando…
Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure: A (123)I meta-iodobenzylguanidine ((123)I MIBG) scintigraphic study
OBJECTIVE: Impaired parasympathetic and sympathetic nervous system activity have been demonstrated in patients with diabetes mellitus (DM) and correlated with worse prognosis. Few data are available on the effect of DM on cardiac neuropathy in heart failure (HF). The aim of the current study was to...
Autores principales: | Paolillo, Stefania, Rengo, Giuseppe, Pagano, Gennaro, Pellegrino, Teresa, Savarese, Gianluigi, Femminella, Grazia D., Tuccillo, Marianna, Boemio, Antonio, Attena, Emilio, Formisano, Roberto, Petraglia, Laura, Scopacasa, Francesco, Galasso, Gennaro, Leosco, Dario, Trimarco, Bruno, Cuocolo, Alberto, Perrone-Filardi, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714495/ https://www.ncbi.nlm.nih.gov/pubmed/23530014 http://dx.doi.org/10.2337/dc12-2147 |
Ejemplares similares
-
Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure
por: Veltman, Caroline E., et al.
Publicado: (2012) -
(123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation
por: Gargiulo, Paola, et al.
Publicado: (2022) -
Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009) -
(123)I-Meta-iodobenzylguanidine Sympathetic Imaging: Standardization and Application to Neurological Diseases
por: Nakajima, Kenichi, et al.
Publicado: (2016) -
Cardiac (123)I-mIBG Imaging in Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2022)